...
首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease.
【24h】

High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease.

机译:高水平的粘附分子与外周动脉疾病患者内皮依赖性血管舒张受损有关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cellular adhesion molecule-1 (sVCAM-1) were measured alongside flow-mediated vasodilation (FMD) in 34 patients with intermittent claudication and 14 control subjects. Patients with plasma sICAM-1 >253 ng/mL (median value) showed lower FMD than those with sICAM-1 < 253 ng/mL (5.6 +/- 1.8% vs 9.6 +/- 4.2%, p < 0.01). Similarly, in the 17 patients with plasma sVCAM-1 > 414 ng/mL, FMD was lower than in the remaining 17 patients (6.1 +/- 1.9% vs 9.2 +/- 4.5%, p < 0.05). Additionally, when endothelial dysfunction was defined as FMD < or = 5.5%, patients with FMD below this value had higher plasma concentrations of sICAM-1 and sVCAM-1 than those with FMD > 5.5%. Therefore, our findings indicate a close association between elevated plasma levels of adhesion molecules and endothelial dysfunction. As impaired endothelial function is one of the first steps in atherogenesis, our findings have clinical relevance since they serve as the basis for further evaluation of sICAM-1 and sVCAM-1 as potential plasma markers for progression of atherosclerosis in a population at high risk.
机译:在34例间歇性lau行患者和14例对照受试者中,测量了可溶性细胞间粘附分子1(sICAM-1)和血管细胞粘附分子1(sVCAM-1)以及血流介导的血管舒张(FMD)。血浆sICAM-1> 253 ng / mL(中位数)的患者显示的FMD低于sICAM-1 <253 ng / mL的患者(5.6 +/- 1.8%vs 9.6 +/- 4.2%,p <0.01)。同样,在血浆sVCAM-1> 414 ng / mL的17例患者中,FMD低于其余17例(6.1 +/- 1.9%对9.2 +/- 4.5%,p <0.05)。此外,当将内皮功能障碍定义为FMD <或= 5.5%时,FMD低于该值的患者的血浆sICAM-1和sVCAM-1的血浆浓度高于FMD> 5.5%的患者。因此,我们的发现表明血浆粘附分子水平的升高与内皮功能障碍之间有着密切的联系。由于内皮功能受损是动脉粥样硬化发生的第一步,因此我们的发现具有临床意义,因为它们可作为进一步评估sICAM-1和sVCAM-1的基础,而sICAM-1和sVCAM-1是高危人群中动脉粥样硬化进展的潜在血浆标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号